120 Participants Needed

Nerve Blocks for Breast Surgery Pain

Recruiting at 1 trial location
RV
AB
Overseen ByAbhijit Biswas, MD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Western University, Canada
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new methods to improve pain management and recovery for patients undergoing breast surgery. The goal is to reduce pain, potentially leading to quicker hospital discharge and better overall patient care.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you use opioids daily over 30 mg of oxycodone or equivalent, you may not be eligible to participate.

Is the nerve block treatment for breast surgery pain generally safe for humans?

The nerve block treatments, such as the Pecto-intercostal Fascial Block (PIFB) and Serratus Plane Block (SPB), have been used in various surgeries and are generally considered safe when performed under ultrasound guidance, which helps ensure accurate placement and reduces risks.12345

How does the nerve block treatment for breast surgery pain differ from other treatments?

This treatment is unique because it uses nerve blocks like the Parasternal Block (PSB) and Thoracic Transversus Plane Block (TTP) to specifically target and relieve pain in the internal mammary region, which other common nerve blocks like the Pectoral Nerve Block (PECS) and Serratus Plane Block (SPB) do not effectively address.15678

What data supports the effectiveness of this treatment for breast surgery pain?

Research shows that combining different nerve blocks, like the serratus plane block and parasternal block, can effectively reduce pain after breast surgery. These blocks target specific nerves to provide better pain relief in areas that are often difficult to manage with other methods.14589

Who Is on the Research Team?

AB

Abhijit Biswas, MD

Principal Investigator

London Health Sciences Center, Western University, London. Ontario. Canada

Are You a Good Fit for This Trial?

This trial is for women aged 18-70, with a physical status classified as ASA I to III, undergoing bilateral breast reduction surgery as a day procedure. It's not specified who can't join the trial.

Inclusion Criteria

I am undergoing or have undergone day surgery procedures.
I am in good to moderate health with or without severe systemic disease.
I am having surgery to reduce the size of both my breasts.
See 4 more

Exclusion Criteria

Pregnancy
Allergy to local anesthetic
Psychiatric disorder affecting patient assessment
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Preoperative Management

Participants receive preoperative ultrasound-guided nerve blocks and standard monitoring

1 day
1 visit (in-person)

Intraoperative Management

Participants undergo surgery with standardized general anesthesia and nerve blocks

1 day

Postoperative Management

Participants receive postoperative pain management and are monitored for recovery

24-48 hours

Follow-up

Participants are monitored for safety and effectiveness after treatment, including pain and recovery assessments

6 months
Follow-up meeting at 6 months post-surgery

What Are the Treatments Tested in This Trial?

Interventions

  • Bilateral parasternal infrapectoral block
  • Bilateral serratus plane block
Trial Overview The study is testing two types of nerve blocks—serratus plane block and parasternal infrapectoral block—against placebo, all in combination with general anesthesia for breast reduction surgery. The goal is to see if these blocks improve recovery and reduce hospital stay.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Study GroupActive Control2 Interventions
Ultrasound guided unilateral serratus plane block and unilateral parasternal infrapectoral block with 0.5% ropivacaine.
Group II: Control GroupPlacebo Group2 Interventions
Ultrasound guided unilateral serratus plane block and unilateral parasternal infrapectoral block with 0.9% saline.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Western University, Canada

Lead Sponsor

Trials
270
Recruited
62,500+

Published Research Related to This Trial

A case study of a 60-year-old man with persistent post-thoracotomy pain showed that using Parasternal Block (PSB) and Thoracic Transversus Plane Block (TTP) effectively eliminated pain in the internal mammary region after previous treatments with Pectoral Nerves Block (PECS) and Serratus Plane Block (SPB).
The pain relief achieved with PSB and TTP, combined with hydrodissection using triamcinolone and Ropivacaine, was sustained for at least 3 months, suggesting this approach could be a valuable option for managing residual pain in similar patients.
Ultrasound Guided Transversus Thoracic Plane block, Parasternal block and fascial planes hydrodissection for internal mammary post thoracotomy pain syndrome.Piraccini, E., Biondi, G., Byrne, H., et al.[2019]
The addition of the pectointercostal fascial plane block (PIFB) to the ultrasound-guided serratus anterior plane block (SAPB) significantly reduced the need for intraoperative fentanyl and resulted in lower mean arterial blood pressure and heart rate during surgery, indicating improved hemodynamic stability.
Despite these benefits, both groups showed similar postoperative pain scores and opioid consumption, suggesting that while PIFB may enhance intraoperative analgesia, it does not significantly impact overall postoperative pain management compared to SAPB alone.
Analgesic Effect of Addition of Pectointercostal Block to Serratus Anterior Plane Block in Breast Surgeries: A Randomized, Controlled Trial.Hozien, AI., Helmy, AM., Koptan, HM., et al.[2023]
The serratus-intercostal plane block (SIPB) provides effective perioperative analgesia for patients undergoing partial mastectomy, with sensory loss extending over multiple intercostal spaces for 12 to 24 hours after administration.
In a study involving more than 20 patients, SIPB did not result in sensory loss at the T1 dermatomal distribution, indicating that additional analgesic methods may be necessary when performing axillary dissection.
[Serratus-Intercostal Plane Block for Brest Surgery].Ohgoshi, Y., Yokozuka, M., Terajima, K.[2018]

Citations

Ultrasound Guided Transversus Thoracic Plane block, Parasternal block and fascial planes hydrodissection for internal mammary post thoracotomy pain syndrome. [2019]
Analgesic Effect of Addition of Pectointercostal Block to Serratus Anterior Plane Block in Breast Surgeries: A Randomized, Controlled Trial. [2023]
[Serratus-Intercostal Plane Block for Brest Surgery]. [2018]
Ultrasound-Guided Pectoral Nerve Block I and Serratus-Intercostal Plane Block Alleviate Postoperative Pain in Patients Undergoing Modified Radical Mastectomy. [2020]
Efficacy of serratus anterior plane block versus thoracic paravertebral block for postoperative analgesia after breast cancer surgery - a randomized trial. [2022]
Effects of bilateral Pecto-intercostal Fascial Block for perioperative pain management in patients undergoing open cardiac surgery: a prospective randomized study. [2022]
Comparison of Ultrasound-Guided Pecto-intercostal Fascial Block and Transversus Thoracic Muscle Plane Block for Acute Poststernotomy Pain Management After Cardiac Surgery: A Prospective, Randomized, Double-Blind Pilot Study. [2022]
Impact of pectoral nerve block on postoperative pain and quality of recovery in patients undergoing breast cancer surgery: A randomised controlled trial. [2022]
Pectoralis-serratus interfascial plane block vs thoracic paravertebral block for unilateral radical mastectomy with axillary evacuation. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security